We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

151 hedge funds and large institutions have $746M invested in Immunogen Inc in 2015 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 48 increasing their positions, 52 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 12

53% more call options, than puts

Call options by funds: $4.04M | Put options by funds: $2.64M

8% more funds holding

Funds holding: 140151 (+11)

8% less repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 52

34% less capital invested

Capital invested by funds: $1.13B → $746M (-$387M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
151
Holders Change
+11
Holders Change %
+7.86%
% of All Funds
4.22%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
24
Increased
48
Reduced
52
Closed
12
Calls
$4.04M
Puts
$2.64M
Net Calls
+$1.4M
Net Calls Change
-$1.8M
Name Holding Trade Value Shares
Change
Change in
Stake
Prudential Financial
26
Prudential Financial
New Jersey
$4.09M +$551K +37,700 +10%
GIM
27
Granahan Investment Management
Massachusetts
$3.85M -$263K -18,000 -4%
Renaissance Technologies
28
Renaissance Technologies
New York
$3.78M +$5.75M +393,440 New
TCIM
29
TIAA CREF Investment Management
New York
$3M -$285K -19,468 -6%
Charles Schwab
30
Charles Schwab
California
$2.89M +$260K +17,781 +6%
BIM
31
BlackRock Investment Management
Delaware
$2.74M -$90.4K -6,181 -2%
CS
32
Candriam SCA
Luxembourg
$2.29M -$905K -61,900 -21%
NI
33
Numeric Investors
Massachusetts
$1.67M +$1.51M +103,300 +145%
LK
34
Lumbard & Kellner
New Hampshire
$1.6M +$16.1K +1,100 +0.7%
Citigroup
35
Citigroup
New York
$1.54M +$309K +21,153 +15%
AllianceBernstein
36
AllianceBernstein
Tennessee
$1.52M -$251K -17,186 -10%
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$1.51M -$2.92K -200 -0.1%
Natixis Advisors
38
Natixis Advisors
Massachusetts
$1.43M -$70.2K -4,803 -3%
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$1.31M
Swiss National Bank
40
Swiss National Bank
Switzerland
$1.25M +$212K +14,500 +13%
TA
41
Teachers Advisors
New York
$1.24M +$5.37K +367 +0.3%
PP
42
PDT Partners
New York
$1.23M +$1.87M +127,584 New
MIG
43
Mariner Investment Group
New York
$1.18M -$453K -31,000 -20%
TFCP
44
Twin Focus Capital Partners
Massachusetts
$1.16M
CCMH
45
Cornerstone Capital Management Holdings
New York
$1.14M +$1.4M +95,600 +409%
GC
46
Guggenheim Capital
Illinois
$1.13M +$1.72M +117,783 New
AQR Capital Management
47
AQR Capital Management
Connecticut
$1.13M +$1.71M +117,183 New
American Century Companies
48
American Century Companies
Missouri
$1.09M +$133K +9,098 +9%
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$1.08M +$1.21M +82,596 +275%
USAA
50
United Services Automobile Association
Texas
$972K -$263K -18,000 -15%

IMGN Hedge Fund Activity: Q3 2015 in Review

151 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q3 2015, worth a combined $746M — down 34% from $1.13B a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new IMGN positions and 12 closed out — a net gain of 12 holders — while 48 added to existing stakes and 52 trimmed.

The largest buyer was OrbiMed, adding an estimated $37.5M. The largest seller was Millennium Management, cutting an estimated $35.3M.

  • 151 institutional investors held Immunogen Inc (IMGN) as of Q3 2015, up from 140 in Q2 2015.
  • Funds reported $746M of Immunogen Inc stock for Q3 2015, down 34% quarter-over-quarter.
  • 24 funds opened new Immunogen Inc positions in Q3 2015 and 12 closed out, a net change of +12 holders.
  • The largest Immunogen Inc buyer in Q3 2015 was OrbiMed, an estimated $37.5M added.
  • The largest Immunogen Inc seller in Q3 2015 was Millennium Management, an estimated $35.3M sold.

Based on aggregated 13F filings for Q3 2015.